Making India Easy · 07. January 2020
The Indian pharmaceutical industry has a variety of characteristics that help it stand out from the rest. It has branded generics dominating the retail market with a share of about 70-80%. Local players are ruling the roost thanks to early investments and formulation development capabilities. And, last but not the least, low price levels driven by a really strong domestic competition. Enhanced medical infrastructure and growing income levels are two key factors that are driving the growth in...
Making India Easy · 04. December 2019
With 6.1% growth rate for fiscal year 2018-19, India is now the world’s fastest growing economy in the world along with China. In fact, the country’s economy is doing far better than other countries (including developed countries) as per World Economic Outlook (WEO) released by International Monetary Fund (IMF). According to IMF’s Chief Economist Gita Gopinath, the global economy is undergoing a huge slowdown and China’s growth will also be affected by it in the coming year. However,...
Making India Easy · 20. November 2019
India has once again topped the list of the fastest growing economies in the world along with China. The overall growth in the economy has substantially encouraged growth in other crucial sectors of the economy also such as pharmaceuticals. As a result, the Indian pharmaceutical is now hailed as one of the world’s most progressive sectors. The industry is a mine of gold for companies planning to expand their businesses to India. We bring to you 10 reasons why investing in the Indian...
Making India Easy · 17. October 2019
The Indian pharmaceutical industry is one of the largest and most advanced in the world. It supplies a whopping 50% of global demand for a wide range of vaccines, 40% of generic demand in the United States, and 25% of all sorts of medicines in the United Kingdom. The country’s increasing pool of prodigious scientists and engineers is driving the industry to new heights. According to a report, Indian pharmaceutical firms supply more than 80% of global demand for antiretroviral drug used to...